In a major victory for women with breast implants, a Louisiana jury found Dow Chemical Company guilty of intentionally deceiving women about the safety of its silicone breast implants. The jury also found that the company had not adequately tested the implants before placing them on the market. This decision, announced on Monday, August 18, ends the first part of a two-part class action lawsuit brought against Dow by 1,800 women who had received breast implants. In the next phase, scheduled to begin in September, the jury will decide whether these women were injured by the implants and to what compensation they are entitled. Prior to this decision, breast-implant manufacturers had been winning the majority of lawsuits.